Ocular Hypertension Completed Phase 2 Trials for Netarsudil (DB13931)

Also known as: Hypertension Ocular / Intraocular pressure high / Intraocular hypertension / Intraocular pressure raised / Ocular Hypertension (OHT) / Ocular Hypertension (OH) / Hypertension, Ocular / Elevated Intraocular Pressure / Intraocular pressure increased / IOP increased / Raised IOP / Ocular tension increased / Tension ocular increased / Pressure intraocular increased / Increased intraocular pressure

IndicationStatusPhase
DBCOND0074237 (Ocular Hypertension)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03844945Efficacy and Systemic Safety of Netarsudil 0.01%, 0.02%, 0.04% Relative to Placebo in Subjects With Open-angle Glaucoma or Ocular Hypertension in JapanTreatment
NCT02057575Study Assessing Safety and Efficacy of PG324 Ophthalmic Solution in Patients With Elevated Intraocular PressureTreatment
NCT01528787Study of AR-13324 in Patients With Elevated Intraocular PressureTreatment
NCT01731002Study Comparing the Safety and Efficacy of AR-13324 to Latanoprost in Patients With Elevated Intraocular PressureTreatment
NCT02874846Nocturnal/Diurnal Intraocular Pressure-Lowering Effect of Netarsudil Ophthalmic SolutionTreatment